Advanced Science News
Content curated by ASN staff
Combating KRAS Mutant Metastatic Colorectal Cancer

Combating KRAS Mutant Metastatic Colorectal Cancer

A new targeted chemotherapeutic nano-medicine NANOPt-pan, composed of Panitumumab and DACHPt (the active form of Oxaliplatin), could passively and actively target EGFR over-expressing tumors and effectively target both KRAS wild type- and mutant-tumors.